When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
An update on the 20 life sciences companies Numenor Capital has profiled so far range from cell therapy companies like SQZ Biotech and Orchard Therapeutics to biologics platforms like Pandion.
The best performing investment, over 170% return, so far has been Pandion Therapeutics that was recently acquired by Merck.
The worst investment so far has been Delcath Systems, around -34%, whose recent clinical trial readout on their drug/device combo was not well received by the market.